Strategic Overview

Bioneer is a South Korean biotechnology company developing molecular tests for TB drug resistance.

Innovation Portfolio

IRON qPCR RFIA
Category: DRUG RESISTANCE Stage: Late Stage

Quantitative PCR with rapid fluorescence immunoassay detection for MTBC and rifampicin resistance. Designed for point-of-care drug resistance screening.

Molecular Sputum

Key Milestones

IRON qPCR RFIA drug resistance test
Limit of detection: 80.5 CFU/mL
40-minute turnaround time
Primary-level capability